Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders
WOBURN, Mass.–(BUSINESS WIRE)–Neurogastrx, Inc., a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal…
Wintermar Offshore (WINS:JK) Reports 9M2025 Results
Star Plus Legend (6683.HK) Becomes a Strategic Shareholder of Galaxy
Geekvape SOUL II Wins 2025 MUSE Gold Award – A Testament to Strength and Innovation
AI Pets Platform FurGPT Prepares to List FGPT Token on Binance Exchange and Aster DEX
Beyond Music, Beyond Worlds – X:THELABEL Rewrites the Rules of Virtual K-Pop